UK approval for AbbVie Crohn’s disease drug
AbbVie has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved…
February 3, 2023 - 3 minutes
Gastro-intestinal disease
Sosei Heptares signs R&D agreements on gastrointestinal and immune disorders
Sosei Heptares has entered translational medicine and R&D agreements with the MRC Weatherall Institute of…
December 8, 2022 - 3 minutes
Delayed release tablets to treat ulcerative colitis launched in Canada
With Canada having one of the highest incidences of ulcerative colitis in the world, the…
October 25, 2022 - 2 minutes
Researchers try to bridge gap in link for patients with salmonella infection and clogged arteries
Researchers from Taiwan have discovered that patients with non-typhoidal salmonella (NTS) have higher aortic calcification…
August 31, 2022 - 4 minutes
Bactolife receives $5M in new funding to address gut infections worldwide
Bactolife has received an investment of $5 million from The Bill & Melinda Gates Foundation…
August 30, 2022 - 2 minutes
French Juvisé buys gastro product in €400M finance deal
French pharmaceutical company, Juvisé has just bought worldwide commercial rights to Pylera from US biopharmaceutical…
July 7, 2022 - 2 minutes
